August 23rd 2023
The USPSTF particularly emphasizes effective communication with patients, including adherence support and calls for reducing barriers to PrEP for racial, ethnic, and other minority groups.
December 30th 2022
Patient Care Guideline Toplines summarize newly revised and updated clinical recommendations from professional societies for convenient, at-a-glance review.
December 23rd 2022
Lenacapavir is the first of a new class of antiretrovirals, and it is indicated for persons with multidrug resistance, intolerance, or safety considerations.
June 28th 2022
New data showed a sharp drop in HIV tests administered in health care and non-health care settings from 2019 to 2020—primarily among persons disproportionately affected by HIV.
March 25th 2022
Persons with HIV now have the option to forego initiation of the long-acting injectable with oral formulations of the medications, according to a statement from Viiv Healthcare.
HIV-1 Infection More Virulent in Heterosexual Persons, According to New Study
New study suggests HIV-1 infection is more virulent when transmitted through heterosexual penile-vaginal intercourse than through anal intercourse between men who have sex with men due to transmission bottlenecks.
PrEP for HIV Prevention: A Guideline Update Topline
The CDC update recommends that clinicians advise all sexually active patients about PrEP and includes a new section on prescribing injectable bimonthly cabotegravir.
The End of the HIV Pandemic: Whatever Happened to 90-90-90 by 2020?
Get 90% of all HIV-infected persons diagnosed, get 90% of them on ART, and get 90% of those on ART “undetectable.” Are we there yet?
AAP Recommends Routine HIV Screening for all Adolescents Starting at Age 15
The AAP updated its guidance to recommend routine HIV screening at least once in all adolescents aged ≥15 years and at-risk youth be rescreened annually.
New Analysis Projects Older Ages and Rising Number of Patients with HIV by 2030
Nearly 25% of patients with HIV who use antiretroviral therapy will reach 65 years of age or older by 2030, researchers projected in a new analysis.
Black Women with HIV at Highest Risk for Premature Mortality a 21-year Study Finds
IDWeek 2021: Despite declining mortality rates among patients with HIV in the past 2 decades, a new study finds significant disparities in gender and race.
People Living with HIV Use Fewer Essential Clinical Services and Less Frequently During Pandemic
Viral-load monitoring rates decreased and clinic visits declined overall despite an increase in use of telehealth.
HIV Infection Linked to Elevated Risk for Sudden Cardiac Death in Veterans, New Study Shows
Patients with HIV had a 14% higher risk of sudden cardiac death than those without HIV, according to a large analysis of US veterans.
Vaccine Hesitancy in Georgia HIV Clinic Reflects Well-worn Myths, Resistance to Facts
Rodger MacArthur, MD, was in his HIV clinic last week and queried his COVID-19 vaccine-hesitant/resistant patients about their reasons. The refrain was familiar and discouraging.
Novavax, J&J Vaccine Candidates Effective Against COVID-19, Variants
Vaccines from both companies were significantly effective against COVID-19 and show promise against variants from the UK and South Africa.
FDA Approval Granted for First Long-acting Injectable HIV Therapy
Cabotegravir and rilpivirine, injectable formulation is administered once-weekly, reducing treatment days for adults with HIV from 365 to 12.
FDA Announced Approval of Second HIV-Prevention Drug
The FDA announced October 3 approval of Descovy®, making it the second drug to receive indication for HIV pre-exposure prophylaxis.
How to Address the HIV-STI Syndemics
The underpinnings of the global HIV and STI epidemics are inextricable. A new report looks at combined solutions. We offer highlights.
10 New Drugs for Primary Care: Q1 2019
Highlights: The first liquid solution of colchicine for prophylaxis of gout, the first generic version of Advair Diskus, and 8 more new and approved drugs.
HCV/HIV-coinfected Patients Recover Liver Function with All-oral DAA Therapy
A first-of-its-kind study found that among cirrhosis patients with and without HIV-coinfection, liver function improved >50% in each cohort.
Top 5 HIV Apps for Primary Care Providers
What are the top 5 HIV/AIDS apps that both physicians and patients can use? Scroll through our new slideshow to find out.
Pre-exposure HIV Prophylaxis Works
Further hope for prevention of transmission as the search for a cure continues.
HIV-Positive Organ Transplant
Research supports liver and kidney transplantation in patients with HIV infection, but referral rates are low.
NCCN Guidelines for Cancer in HIV: A Quiz
Test your knowledge of the latest National Comprehensive Cancer Network guidelines for cancer in patients with HIV infection.
PrEP Use Growing in the US and Worldwide
The use of pre-exposure prophylaxis for HIV prevention among men who have sex with men has doubled each year since 2012.
Low Condom Use During Oral/Anal Sex Puts Heterosexuals at Risk
Both oral and anal sex have been linked to an increased risk of STD and HIV transmission in heterosexuals, say CDC researchers.
Why Southern Women Are Hit Hardest by HIV
Structural barriers may explain the HIV epidemic among women in the American South.
Odds of Cognitive Impairment in Women vs Men With HIV
Findings from the largest study to evaluate sex differences in HIV-related cognitive dysfunction.
HIV Self-Tests as Accurate as Tests by Healthcare Workers
This study may help alleviate doubts about whether laypersons can perform the test and interpret the results correctly on their own.
Chemsex/Slamsex and STIs: What are the Risks?
Results of this study suggest a combined epidemic of sexual ill-health, drug use harms, and mental illness among HIV-positive MSM who engage in slamsex and chemsex.
9 New Drugs for Primary Care: Q1 2018
The "new year" is now in full swing and new drugs are being approved each month; check out our slideshow to get up to date on 9 drugs approved in the first quarter for primary care.
PrEP May Increase STI Risk
PrEP can decrease risk of HIV transmission. It can also contribute to risky sexual behavior and STIs.
Antiretrovirals Linked to Worse Neurodevelopment in Young Kids
The population of children who had prenatal exposure to HIV and to antiretroviral agents who do not become infected with HIV is growing. What effect do ARVs have on neurodevelopment in this group?
Weak, Wobbly, and He Can't Look Up
A 34-year-old man with a history of HIV says family members are exaggerating his symptoms but that the headache and double vision are bothersome.
Second Generation Direct-Antivirals for HCV in the Real World
Clinical trials of second generation direct-acting antivirals in HCV show high cure rates. But do those rates reflect real life?
2 Clarke Drive Cranbury, NJ 08512